Real-time enrollment status for this primary cns lymphoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:10 AM UTC
| NCT Number | NCT03328078 |
| Recruiting Status | Recruiting |
| Condition | Primary CNS Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 152 participants |
| Active Locations | 27 sites in the US |
| Sponsor | Curis, Inc. |
| Last Updated on CT.gov | June 5, 2025 (Jun 5, 2025) |
As of March 2, 2026: Clinical trial NCT03328078 is currently recruiting participants. This clinical trial study for primary cns lymphoma is actively seeking new participants at 27 locations across the United States. The study is sponsored by Curis, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03328078 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 27 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03328078 was last updated Jun 5, 2025 (June 5, 2025). HelloStudys verifies this status automatically.